Search results for "AGENT"

showing 10 items of 8904 documents

Systemic immunosuppression in times of COVID‐19: Do we need to rethink our standards?

2020

Summary The current SARS‐CoV‐2 pandemic particularly endangers older people with pre‐existing cardiopulmonary and metabolic conditions. However, it is also currently under discussion whether patients under immunosuppressive therapy also have a higher risk of suffering a severe course of the COVID‐19 disease. In principle though, there is currently no data available for a general reduction or pause of immunosuppression in patients with autoimmune diseases because of the SARS‐CoV‐2 pandemic. However, since there is currently neither an effective therapy nor corresponding vaccination protection, the indication for a prolonged immunosuppressive therapy should be made with special care. In parti…

medicine.medical_specialtymedicine.medical_treatment610 MedizinDiseaseReviewDermatologyAntiviral Agents030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineChloroquine610 Medical sciencesPandemicMedicineHumansIntensive care medicineImmunosuppression Therapybusiness.industryCOVID-19HydroxychloroquineImmunosuppressionChloroquineCOVID-19 Drug TreatmentCalcineurinVaccinationDoxycyclineRituximabbusinessmedicine.drugHydroxychloroquineJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Intravenous thrombolysis for acute ischaemic stroke in patients on direct oral anticoagulants.

2018

BACKGROUND AND PURPOSE Whereas intravenous thrombolysis (IVT) is allowed for acute ischaemic stroke in patients on vitamin K antagonists with international normalized ratio ≤1.7, there are no similar recommendations for patients on direct oral anticoagulants (DOACs), notably due to the lack of coagulation tests to assess the therapeutic effects. Although the literature is scarce, consisting of small case series and retrospective studies, considering the frequency of this situation the French Vascular Neurology Society and the French Study Group on Haemostasis and Thrombosis have worked on a joint position paper to provide a practical position regarding the emergency management of ischaemic …

medicine.medical_specialtymedicine.medical_treatmentAdministration Oral030204 cardiovascular system & hematologyAntithrombinsDabigatranBrain Ischemia03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanAtrial FibrillationCoagulation testingMedicineHumansThrombolytic TherapyStrokeRetrospective StudiesProthrombin timeRivaroxabanmedicine.diagnostic_testbusiness.industryAnticoagulantsIdarucizumabThrombolysismedicine.diseaseDabigatranStrokeNeurologyEmergency medicineAdministration IntravenousNeurology (clinical)Blood Coagulation Testsbusiness030217 neurology & neurosurgeryPartial thromboplastin timemedicine.drugFactor Xa InhibitorsEuropean journal of neurology
researchProduct

Usefulness of Stress Echocardiography in the Management of Patients Treated with Anticancer Drugs.

2021

In recent years, the survival of patients with cancer has improved thanks to advances in antineoplastic therapeutic protocols. This has led to an increasing burden of cardiovascular complications related to cancer treatment. Therefore, a new branch of cardiology has been created, ``cardio-oncology,'' with the aims of preventing cardiovascular complications related to antineoplastic treatment, achieving early diagnosis and treatment of any complications, and allowing completion of the expected antineoplastic treatment. Stress echocardiography has a pivotal role in achieving a timely diagnosis of coronary artery disease and thus is the best management approach in this clinical setting. Athero…

medicine.medical_specialtymedicine.medical_treatmentAntineoplastic Agents030204 cardiovascular system & hematologyCoronary artery disease030218 nuclear medicine & medical imagingCoronary artery diseaseAntineoplastic Agent03 medical and health sciences0302 clinical medicineAntineoplastic therapeutic protocolsEchocardiography StreNeoplasmsAntineoplastic therapeutic protocolmedicineStress EchocardiographyHumansRadiology Nuclear Medicine and imagingIn patientCADIntensive care medicineAntineoplastic therapeutic protocols CAD Cardio-oncology Cardiotoxicity Coronary artery disease Stress echocardiography Cardiotoxicity Early Detection of Cancer Echocardiography Echocardiography Stress Humans Antineoplastic Agents NeoplasmsEarly Detection of CancerSubclinical infectionChemotherapyCardiotoxicitybusiness.industryCancerAntineoplastic therapeutic protocols; CAD; Cardio-oncology; Cardiotoxicity; Coronary artery disease; Stress echocardiographymedicine.diseaseCardiotoxicityCardio-oncologyStress echocardiographyAnticancer treatmentEchocardiographyCardiology and Cardiovascular MedicinebusinessHumanEchocardiography StressJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review.

2020

Introduction: Metronomic dosing is used to give continuous chemotherapy at low doses. The low doses have minimal side effects and may enable cancer treatment to be remodeled toward the management o...

medicine.medical_specialtymedicine.medical_treatmentAntineoplastic Agents030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineClinical Trials Phase II as TopicNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansRadiology Nuclear Medicine and imagingDosingIntensive care medicineRandomized Controlled Trials as TopicChemotherapybusiness.industryLow doseHematologyGeneral MedicineProgression-Free SurvivalCancer treatmentClinical trialSurvival RateSystematic reviewOncologyClinical Trials Phase III as TopicClinical evidence030220 oncology & carcinogenesisAdministration MetronomicbusinessActa oncologica (Stockholm, Sweden)
researchProduct

Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression?

2005

PURPOSE OF REVIEW The success of an antihypertensive treatment is difficult to estimate by the extent of blood pressure reduction alone. Above and beyond blood pressure values in an individual patient, it is necessary to monitor the impact of antihypertensive treatment on the development or regression of hypertension-induced early end-organ damage. The intermediate objectives or surrogate endpoints may provide additional valuable information about the level of success of a given therapy in a particular patient. Moreover, monitoring intermediate objectives may provide scientific evidence for delineating the best antihypertensive treatment. RECENT FINDINGS The importance of assessing left ven…

medicine.medical_specialtymedicine.medical_treatmentBlood PressureLeft ventricular hypertrophyEssential hypertensionInternal medicineDiabetes mellitusDiabetes MellitusInternal MedicinemedicineAlbuminuriaHumansAntihypertensive AgentsReduction (orthopedic surgery)business.industrySurrogate endpointmedicine.diseaseCarotid ArteriesBlood pressureNephrologyHypertensionCardiologyAortic pressureHypertrophy Left VentricularMicroalbuminuriabusinessCurrent Opinion in Nephrology & Hypertension
researchProduct

Infliximab and ulcerative colitis

2006

Expert Opin Biol Ther. 2006 Apr;6(4):401-8. Infliximab and ulcerative colitis. Cottone M, Mocciaro F, Modesto I. Università di Palermo, Istituto di Medicina Generale e Pneumologia, Via Trabucco 180, Palermo, Italy. dickens@tin.it Tumour necrosis factor (TNF)-alpha is an inflammatory cytokine that plays a main role in the inflammatory process underlying inflammatory bowel disease (IBD). Despite the fact that the cytokine profiles associated with ulcerative colitis (UC) and Crohn's disease (CD) are classically considered different (a Th2 pattern in UC and a Th1 pattern in CD), there are several evidences in vitro and in vivo that TNF-alpha has an important role in UC. For this reason, inflixi…

medicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryInflammatory bowel diseaseGastroenterologyGastrointestinal AgentsInternal medicineDrug Discoverymedicineinfliximab. ulcerative colitisHumansColitisPharmacologyGastrointestinal agentbusiness.industryAntibodies MonoclonalPouchitismedicine.diseaseUlcerative colitisInfliximabInfliximabCytokineImmunologyColitis UlcerativeTumor necrosis factor alphabusinessmedicine.drugExpert Opinion on Biological Therapy
researchProduct

Antimicrobial prophylaxis in allogeneic bone marrow transplantation. Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Societ…

2005

Patients undergoing allogeneic stem cell transplantation are at high risk for infection with a variety of pathogens during different phases of the procedure. Bacteria and fungi predominate the first phase until engraftment. During the second phase, from engraftment to about day 100, major infectious problems are caused by fungi and cytomegalovirus. Both pathogens remain important under continued immunosuppression, however, in the late post-transplantation period infections with encapsulated bacteria may become a problem. In this review the Infectious Diseases Working Party of the DGHO gives recommendations for prophylaxis of infections under allogeneic stem cell transplantation with drugs a…

medicine.medical_specialtymedicine.medical_treatmentCongenital cytomegalovirus infectionHematopoietic stem cell transplantationNeutropenia03 medical and health sciences0302 clinical medicineAnti-Infective AgentsmedicineHumansTransplantation HomologousInfection controlAntibiotic prophylaxisIntensive care medicineBone Marrow TransplantationInfection Controlbusiness.industryImmunosuppressionHematologyAntibiotic ProphylaxisAntimicrobialmedicine.disease3. Good healthTransplantationOncology030220 oncology & carcinogenesisImmunologyPreventive Medicinebusiness030215 immunologyAnnals of Oncology
researchProduct

LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Re…

2021

<b><i>Background:</i></b> Hidradenitis suppurativa (HS) is a chronic, inflammatory, burdensome skin disease where medical first-line treatment is still limited to long-term, topical and/or systemic antibiotics. The RELIEVE study aimed at evaluating the efficacy of LAight® therapy – a combination of intense pulsed light and radiofrequency – as an adjunct treatment to first-line therapies in Hurley stage I and II HS. <b><i>Methods:</i></b> The RELIEVE study was performed as a two-period multicenter randomized controlled trial with blinded assessment. For period A from week 0 to week 16, the 88 participating subjects were randomized into either a…

medicine.medical_specialtymedicine.medical_treatmentDermatologyIntense pulsed lightSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawInternal medicineClinical endpointMedicineHumansHidradenitis suppurativabusiness.industryClindamycinClindamycinmedicine.diseaseTreatment efficacyAnti-Bacterial AgentsHidradenitis SuppurativaTreatment OutcomeTopical clindamycinChronic DiseaseQuality of Lifebusinessmedicine.drugDermatology (Basel, Switzerland)
researchProduct

The Effects of Epinine on Arterial Blood Pressure and Regional Vascular Resistances in Anesthetized Rats

1998

1. We carried out experiments in anesthetized rats to study the hemodynamic effects of intravenous injections of epinine. 2. Epinine (1-320 micrograms/kg) produced a biphasic effect on mean arterial blood pressure (n = 30). At doses lower than 40 micrograms/kg, arterial blood pressure decreased (by as much as 21.5 +/- 3.4%), though at higher doses it increased dose dependently (by as much as 73.2 +/- 14.5%). Epinine also produced bradicardia in a dose-dependent manner (by as much as 26.4 +/- 4.9%). Sulpiride (100 micrograms/kg) suppressed the hypotensive effect of epinine but did not change the hypertensive effect. In the presence of prazosin (1,000 micrograms/kg), arterial blood pressure r…

medicine.medical_specialtymedicine.medical_treatmentHemodynamicsBlood PressureAntiarrhythmic agentUrethaneRenal CirculationHeart RateInternal medicinemedicinePrazosinAnimalsSplanchnic CirculationRats WistarPharmacologybusiness.industryBlood flowRatsDeoxyepinephrinemedicine.anatomical_structureBlood pressureEndocrinologyDopamine AgonistsCirculatory systemVascular resistanceVascular ResistanceSulpiridebusinessAnesthetics Intravenousmedicine.drugGeneral Pharmacology: The Vascular System
researchProduct

Hepatitis C virus infection in hemodialyzed patients.

2007

In spite of our present improved knowledge of the epidemiology and pathways of contamination of the hepatitis C virus (HCV), infection still remains a public health problem. One category of patients who have suffered greatly from the consequences of HCV infection is certainly that of hemodialysis patients. In the past, in fact, their need for transfusions exposed these patients to infection and, as a result, subjects on dialysis for over 15 years are today paying the price for those inevitable transfusions, as the virus and its pathways of contagion were unknown then. However, still today, albeit at a much lower prevalence, even subjects with a shorter dialysis age present a higher prevalen…

medicine.medical_specialtymedicine.medical_treatmentHepatitis C virusPopulationBiomedical EngineeringMedicine (miscellaneous)Bioengineering030204 cardiovascular system & hematologymedicine.disease_causeAsymptomaticAntiviral AgentsBiomaterials03 medical and health scienceschemistry.chemical_compoundLiver disease0302 clinical medicineRenal DialysisRisk FactorsInternal medicinemedicineHumanseducationDialysiseducation.field_of_studybusiness.industryRibavirinMortality rateTransfusion ReactionGeneral Medicinemedicine.diseaseHepatitis Cchemistry030220 oncology & carcinogenesisImmunologyHemodialysismedicine.symptombusinessThe International journal of artificial organs
researchProduct